{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2018-N-4627\" sorted by posted_date descending", "rows": [["FDA-2018-N-4627-0018", "FDA", "FDA-2018-N-4627", "Letter from Medical Device Manufacturers Association to FDA DDM", "Other", "Letter(s)", "2019-05-01T04:00:00Z", 2019, 5, "2019-05-01T04:00:00Z", null, "2019-05-01T20:08:55Z", null, 0, 0, "0900006483c259c3"], ["FDA-2018-N-4627-0017", "FDA", "FDA-2018-N-4627", "Altman - Review of the Mechanisms of Action for Supartz FX in Knee Osteoarthritis (2018)", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:58Z", null, 0, 0, "0900006483b4c012"], ["FDA-2018-N-4627-0008", "FDA", "FDA-2018-N-4627", "Nicholls 2017", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:51Z", null, 0, 0, "0900006483b4c022"], ["FDA-2018-N-4627-0005", "FDA", "FDA-2018-N-4627", "Docket No. FDA-2018-N-4627 Reference List", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:49Z", null, 0, 0, "0900006483b4c050"], ["FDA-2018-N-4627-0004", "FDA", "FDA-2018-N-4627", "Richards 2016", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:48Z", null, 0, 0, "0900006483b4c1ff"], ["FDA-2018-N-4627-0007", "FDA", "FDA-2018-N-4627", "Trouvin - pain in OA - implications for optimal mgt", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:50Z", null, 0, 0, "0900006483b4c023"], ["FDA-2018-N-4627-0013", "FDA", "FDA-2018-N-4627", "Greenberg - Biochemical Effects of Two Different Hyaluronic Acid Products in a Co-Culture Model of Osteoarthritis (2006)", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:55Z", null, 0, 0, "0900006483b4c016"], ["FDA-2018-N-4627-0016", "FDA", "FDA-2018-N-4627", "Altman - The Mechanism of Action for Hyaluronic Acid Treatment in the Osteoarthritic Knee - A Systematic Review (2015)", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:57Z", null, 0, 0, "0900006483b4c013"], ["FDA-2018-N-4627-0011", "FDA", "FDA-2018-N-4627", "Liao - hyaluronan - pharmacological characterization and drug delivery", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:53Z", null, 0, 0, "0900006483b4c018"], ["FDA-2018-N-4627-0002", "FDA", "FDA-2018-N-4627", "Strauss - HA viscosupplementation and OA", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:46Z", null, 0, 0, "0900006483b4c201"], ["FDA-2018-N-4627-0015", "FDA", "FDA-2018-N-4627", "Balazs - Physical Properties of Synovial Fluid and the Special Role of Hyaluronic Acid", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:56Z", null, 0, 0, "0900006483b4c014"], ["FDA-2018-N-4627-0003", "FDA", "FDA-2018-N-4627", "Schaible2009_Article_JointPain", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:47Z", null, 0, 0, "0900006483b4c200"], ["FDA-2018-N-4627-0006", "FDA", "FDA-2018-N-4627", "Vasi - chemical functionalization of HA for drug delivery applications", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:49Z", null, 0, 0, "0900006483b4c024"], ["FDA-2018-N-4627-0010", "FDA", "FDA-2018-N-4627", "Migliore", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:52Z", null, 0, 0, "0900006483b4c019"], ["FDA-2018-N-4627-0014", "FDA", "FDA-2018-N-4627", "Chen 2018", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:56Z", null, 0, 0, "0900006483b4c015"], ["FDA-2018-N-4627-0012", "FDA", "FDA-2018-N-4627", "Jahn - Lubrication of Articular Cartilage (2016)", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:54Z", null, 0, 0, "0900006483b4c017"], ["FDA-2018-N-4627-0009", "FDA", "FDA-2018-N-4627", "Moreland - intra-articular HA etc", "Supporting & Related Material", "Background Material", "2019-03-29T04:00:00Z", 2019, 3, null, null, "2019-03-29T20:37:51Z", null, 0, 0, "0900006483b4c021"], ["FDA-2018-N-4627-0001", "FDA", "FDA-2018-N-4627", "Intent To Consider the Appropriate Classification of Hyaluronic Acid Intraarticular Products Intended for the Treatment of Pain in Osteoarthritis of the Knee Based on Scientific Evidence", "Notice", "Announcement", "2018-12-18T05:00:00Z", 2018, 12, "2018-12-18T05:00:00Z", null, "2018-12-18T13:45:44Z", "2018-27351", 0, 0, "09000064839a90fa"]], "truncated": false, "filtered_table_rows_count": 18, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2018-N-4627"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-4627", "results": [{"value": "FDA", "label": "FDA", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-4627", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-4627", "results": [{"value": 2019, "label": 2019, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&posted_year=2019", "selected": false}, {"value": 2018, "label": 2018, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&posted_year=2018", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-4627&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 670.3347940929234, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}